186 related articles for article (PubMed ID: 10886579)
1. Role of persistent amenorrhea in bone mineral metabolism of young hemodialyzed women.
Weisinger JR; Gonzalez L; Alvarez H; Hernandez E; Carlini RG; Capriles F; Cerviño M; Martinis R; Paz-Martínez V; Bellorín-Font E
Kidney Int; 2000 Jul; 58(1):331-5. PubMed ID: 10886579
[TBL] [Abstract][Full Text] [Related]
2. Bone mineral density and menstrual irregularities. A comparative study on cortical and trabecular bone structures in runners with alleged normal eating behavior.
Tomten SE; Falch JA; Birkeland KI; Hemmersbach P; Høstmark AT
Int J Sports Med; 1998 Feb; 19(2):92-7. PubMed ID: 9562216
[TBL] [Abstract][Full Text] [Related]
3. Hypergonadotropic amenorrhea and bone density: new approach to an old problem.
Devleta B; Adem B; Senada S
J Bone Miner Metab; 2004; 22(4):360-4. PubMed ID: 15221495
[TBL] [Abstract][Full Text] [Related]
4. Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.
Kotzmann H; Riedl M; Pietschmann P; Schmidt A; Schuster E; Kreuzer S; Kainberger F; Frisch H; Geyer G; Hörl WH; Mayer G; Luger A
J Nephrol; 2004; 17(1):87-94. PubMed ID: 15151263
[TBL] [Abstract][Full Text] [Related]
5. Effects of raloxifene on bone metabolism and serum lipids in postmenopausal women on chronic hemodialysis.
Hernández E; Valera R; Alonzo E; Bajares-Lilue M; Carlini R; Capriles F; Martinis R; Bellorin-Font E; Weisinger JR
Kidney Int; 2003 Jun; 63(6):2269-74. PubMed ID: 12753317
[TBL] [Abstract][Full Text] [Related]
6. The effect of sexual hormone abnormalities on proximal femur bone mineral density in hemodialysis patients and the possible role of RANKL.
Doumouchtsis KK; Kostakis AI; Doumouchtsis SK; Grapsa EI; Passalidou IA; Tziamalis MP; Poulakou MV; Vlachos IS; Perrea DN
Hemodial Int; 2008 Jan; 12(1):100-7. PubMed ID: 18271850
[TBL] [Abstract][Full Text] [Related]
7. Skeletal involvement in female acromegalic subjects: the effects of growth hormone excess in amenorrheal and menstruating patients.
Scillitani A; Chiodini I; Carnevale V; Giannatempo GM; Frusciante V; Villella M; Pileri M; Guglielmi G; Di Giorgio A; Modoni S; Fusilli S; Di Cerbo A; Liuzzi A
J Bone Miner Res; 1997 Oct; 12(10):1729-36. PubMed ID: 9333135
[TBL] [Abstract][Full Text] [Related]
8. The association of endogenous hormone concentrations and bone mineral density measures in pre- and perimenopausal women of four ethnic groups: SWAN.
Sowers MR; Finkelstein JS; Ettinger B; Bondarenko I; Neer RM; Cauley JA; Sherman S; Greendale GA;
Osteoporos Int; 2003 Jan; 14(1):44-52. PubMed ID: 12577184
[TBL] [Abstract][Full Text] [Related]
9. Preservation of neuroendocrine control of reproductive function despite severe undernutrition.
Miller KK; Grinspoon S; Gleysteen S; Grieco KA; Ciampa J; Breu J; Herzog DB; Klibanski A
J Clin Endocrinol Metab; 2004 Sep; 89(9):4434-8. PubMed ID: 15356043
[TBL] [Abstract][Full Text] [Related]
10. Bone turnover markers and bone density across the menopausal transition.
Ebeling PR; Atley LM; Guthrie JR; Burger HG; Dennerstein L; Hopper JL; Wark JD
J Clin Endocrinol Metab; 1996 Sep; 81(9):3366-71. PubMed ID: 8784098
[TBL] [Abstract][Full Text] [Related]
11. Low bone mass density at multiple skeletal sites, including the appendicular skeleton in amenorrheic runners.
Pettersson U; Stålnacke B; Ahlénius G; Henriksson-Larsén K; Lorentzon R
Calcif Tissue Int; 1999 Feb; 64(2):117-25. PubMed ID: 9914318
[TBL] [Abstract][Full Text] [Related]
12. Serum prolactin, gonadotropins, and estradiol in menstruating and amenorrheic mothers during two years' lactation.
Delvoye P; Demaegd M; Uwayitu-Nyampeta ; Robyn C
Am J Obstet Gynecol; 1978 Mar; 130(6):635-9. PubMed ID: 637075
[TBL] [Abstract][Full Text] [Related]
13. Bone mineral density and sex hormone status in intellectually disabled women on progestin-induced amenorrhea.
Arvio M; Kilpinen-Loisa P; Tiitinen A; Huovinen K; Mäkitie O
Acta Obstet Gynecol Scand; 2009; 88(4):428-33. PubMed ID: 19330573
[TBL] [Abstract][Full Text] [Related]
14. Clinical and biochemical determinants of bone metabolism and bone mass in adolescent female patients with anorexia nervosa.
Audí L; Vargas DM; Gussinyé M; Yeste D; Martí G; Carrascosa A
Pediatr Res; 2002 Apr; 51(4):497-504. PubMed ID: 11919336
[TBL] [Abstract][Full Text] [Related]
15. Clinical manifestations of low bone mass in amenorrhea patients with elevated follicular stimulating hormone.
Yu Q; Lin S; He F; Li B; Lin Y; Zhang T; Zhang Y
Chin Med J (Engl); 2002 Sep; 115(9):1376-9. PubMed ID: 12411116
[TBL] [Abstract][Full Text] [Related]
16. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
17. Bone density in amenorrheic women with and without hyperprolactinemia.
Schlechte JA; Sherman B; Martin R
J Clin Endocrinol Metab; 1983 Jun; 56(6):1120-3. PubMed ID: 6404918
[TBL] [Abstract][Full Text] [Related]
18. Lumbar bone mineral density in adolescent female runners.
Moen SM; Sanborn CF; DiMarco NM; Gench B; Bonnick SL; Keizer HA; Menheere PP
J Sports Med Phys Fitness; 1998 Sep; 38(3):234-9. PubMed ID: 9830831
[TBL] [Abstract][Full Text] [Related]
19. Serum follicle-stimulating hormone level is a predictor of bone mineral density in patients with hormone replacement therapy.
Kawai H; Furuhashi M; Suganuma N
Arch Gynecol Obstet; 2004 Mar; 269(3):192-5. PubMed ID: 13680264
[TBL] [Abstract][Full Text] [Related]
20. Bone mineral content and levels of gonadotropins and estrogens in amenorrheic running women.
Fisher EC; Nelson ME; Frontera WR; Turksoy RN; Evans WJ
J Clin Endocrinol Metab; 1986 Jun; 62(6):1232-6. PubMed ID: 3700585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
